AquaBounty Technologies, Inc. (AQB) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

AquaBounty Technologies, Inc. (AQB) Consumer Business Overview

AquaBounty Technologies, Inc. operates within the agricultural farm products sector, specializing in bioengineered Atlantic salmon. Their AquAdvantage Salmon aims to enhance productivity in the aquaculture industry, primarily serving the United States and Canada. The company focuses on genetic research and the sale of salmon products.

What Is the Investment Thesis for AQB?

AquaBounty Technologies presents a unique investment opportunity within the aquaculture industry, driven by its innovative AquAdvantage Salmon. The key value driver is the potential for increased production efficiency and reduced time-to-market compared to traditional salmon farming. Growth catalysts include expanding production capacity and securing regulatory approvals in new markets. However, investors may want to evaluate the risks associated with consumer acceptance of genetically engineered food and the regulatory hurdles involved in bringing novel products to market. With a market capitalization of $5.61M and a beta of 1.31, AquaBounty exhibits moderate volatility. The lack of a dividend reflects the company's focus on reinvesting earnings for growth. The company's success hinges on scaling production and gaining wider market acceptance of its AquAdvantage Salmon.

Based on FMP financials and quantitative analysis

AQB Key Highlights

AquaBounty Technologies focuses on enhancing productivity in the commercial aquaculture industry.

• The company's primary product is AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption.
• AquaBounty sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.
• The company engages in genetic, genomic, and fish health and nutrition research activities.
• AquaBounty Technologies has a market capitalization of $5.61M and a beta of 1.31.

Who Are AQB's Competitors?

AQB is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AQB's Key Strengths?

Innovative AquAdvantage Salmon technology.

• First mover advantage in GE salmon market.
• Strong intellectual property protection.
• Focus on sustainable aquaculture practices.

What Are AQB's Weaknesses?

Limited production capacity.

• Dependence on a single product.
• Negative consumer perception of genetically engineered food.
• Regulatory hurdles in new markets.

What Could Drive AQB Stock Higher?

Expansion of production capacity at existing facilities.

• Potential regulatory approvals in new geographic markets by Q4 2026.
• Increasing consumer awareness and acceptance of AquAdvantage Salmon.

What Are the Key Risks for AQB?

Financial-distress signal — its Altman Z-Score of -46.09 sits in the distress zone (elevated bankruptcy risk).

• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Negative consumer perception of genetically engineered food impacting demand.
• Regulatory hurdles and delays in obtaining approvals in new markets.
• Competition from established salmon producers with greater resources.
• Disease outbreaks in aquaculture facilities affecting production volume.

What Are the Growth Opportunities for AQB?

• Expansion of Production Capacity: AquaBounty can increase its revenue by expanding its production facilities and increasing the volume of AquAdvantage Salmon it can bring to market. This includes scaling up existing facilities and potentially building new ones in strategic locations. The global aquaculture market is projected to reach $285 billion by 2030, providing a substantial opportunity for growth if AquaBounty can capture a larger share of the salmon market. This expansion is dependent on securing additional funding and navigating regulatory approvals.
• Geographic Market Expansion: AquaBounty has the opportunity to expand its sales and distribution network beyond its current markets in the United States and Canada. Entering new markets, such as Europe and Asia, could significantly increase its revenue potential. The European salmon market, for example, is a large and established market with a growing demand for sustainable seafood options. This expansion requires navigating different regulatory environments and consumer preferences.
• Product Diversification: While AquAdvantage Salmon is the company's primary product, AquaBounty could explore opportunities to diversify its product line. This could include developing other genetically engineered fish species or offering value-added salmon products. Diversification could reduce the company's reliance on a single product and open up new revenue streams. The market for value-added seafood products is growing, driven by consumer demand for convenient and healthy meal options.
• Strategic Partnerships and Acquisitions: AquaBounty could pursue strategic partnerships or acquisitions to accelerate its growth and expand its capabilities. Partnering with established seafood distributors or acquiring smaller aquaculture companies could provide access to new markets and technologies. The aquaculture industry is consolidating, with larger companies acquiring smaller players to gain market share and expertise. These partnerships could facilitate faster market penetration and technology adoption.
• Technological Advancements: AquaBounty can continue to invest in research and development to further improve the efficiency and sustainability of its aquaculture operations. This could include developing new genetic modifications to enhance fish growth and disease resistance, as well as implementing advanced monitoring and control systems to optimize production. Technological advancements can lead to lower production costs and improved product quality, giving AquaBounty a competitive advantage.

What Are AQB's Competitive Advantages?

• Proprietary AquAdvantage Salmon technology protected by patents.
• First-mover advantage in the genetically engineered salmon market.
• Specialized expertise in aquaculture and genetic engineering.
• Regulatory approvals for AquAdvantage Salmon in key markets.

What Does AQB Do?

AquaBounty Technologies, Inc., established in 1991 and headquartered in Maynard, Massachusetts, is a biotechnology company dedicated to improving productivity within the commercial aquaculture sector. Originally named Aqua Bounty Farms, Inc., the company rebranded in 2004 to reflect its focus on technological advancements. AquaBounty's core product is AquAdvantage Salmon, a genetically engineered Atlantic salmon designed for human consumption. This salmon grows faster than conventional Atlantic salmon, potentially reducing the time and resources required for production. The company engages in genetic, genomic, and fish health and nutrition research to further enhance its aquaculture offerings. In addition to AquAdvantage Salmon, AquaBounty sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company aims to address the growing global demand for seafood through sustainable and efficient aquaculture practices. AquaBounty targets markets in the United States and Canada, seeking to establish its AquAdvantage Salmon as a viable and environmentally responsible alternative to traditional salmon farming.

What Products and Services Does AQB Offer?

• Develop and commercialize genetically engineered Atlantic salmon (AquAdvantage Salmon).
• Conduct genetic, genomic, and fish health research.
• Sell AquAdvantage Salmon for human consumption.
• Sell conventional Atlantic salmon.
• Sell salmon eggs and fry.
• Sell salmon byproducts.

How Does AQB Make Money?

• Generate revenue through the sale of AquAdvantage Salmon.
• Generate revenue through the sale of conventional Atlantic salmon, salmon eggs, and fry.
• Invest in research and development to improve aquaculture productivity.
• Focus on markets in the United States and Canada.

What Industry Does AQB Operate In?

AquaBounty Technologies operates within the agricultural farm products industry, a segment of the broader consumer defensive sector. The aquaculture industry is experiencing growth driven by increasing global demand for seafood and concerns about the sustainability of wild-caught fish. AquaBounty's AquAdvantage Salmon aims to address these trends by offering a more efficient and potentially more sustainable alternative to traditional salmon farming. Competitors include established salmon producers and other aquaculture companies. The company's success depends on its ability to differentiate its product and gain market share in a competitive landscape.

Who Are AQB's Key Customers?

• Seafood distributors
• Retail grocery chains
• Restaurants

Company Profile

AquaBounty Technologies, Inc. operates in the Agricultural Farm Products industry within the Consumer Defensive sector. It is headquartered in Maynard, US. The company is led by CEO David A. Frank. AQB has traded publicly since 2017.

AquaBounty Technologies, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -46.09 places it in the distress zone, a signal of elevated financial risk.

AQB Valuation & Market Position

With a $5.61M market cap, AquaBounty Technologies, Inc. sits in the micro-cap segment of the market.

Quarterly Financial Performance: AquaBounty Technologies, Inc.

Revenue for AquaBounty Technologies, Inc. came in at $0 during Q2 FY2026. The company recorded a net loss of $1.6M, with diluted EPS of $-0.32. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Consumer Defensive. Across the four most recent quarters, AQB averaged $-1.15 in diluted EPS.

AquaBounty Technologies, Inc. has missed Wall Street's EPS estimate in 4 of its last 7 reported quarters — a mixed record worth weighing. Reported results have landed about 714.6% below estimates on average.

The most recent 10 insider filings for AquaBounty Technologies, Inc. break down as 5 sales and 5 purchases. On net that is roughly 47K shares acquired (about $89K) — insiders putting money in tends to read as conviction.

AQB Financials

AQB Latest News

AQB Analyst Consensus

AQB MoonshotScore

Common Questions About AQB (Consumer Defensive)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources